Bayer Purchase Of Schering AG Would Give Firm Focus On Specialty Pharma
This article was originally published in The Pink Sheet Daily
Executive Summary
$19. 5 bil. offer by Bayer will likely thwart hostile takeover of Schering by Merck KgaA.
You may also be interested in...
Bayer Benefits From Diversification, Despite Flat Pharma Growth in 2010
Firm's ability to pursue smaller acquisitions or partnerships is improving because of a reduction in net debt.
Bayer Benefits From Diversification, Despite Flat Pharma Growth in 2010
Firm's ability to pursue smaller acquisitions or partnerships is improving because of a reduction in net debt.
Merck KgaA Steps Aside For Bayer/Schering Merger To Move Forward
Bayer will buy Merck’s shares in Schering AG at €89 per share, or €3 more than the current bid.